文献速递儿童感染儿童神经与发育行为

婴儿腹膜分流管相关脑膜炎的替加环素治疗

Tigecycline Therapy in an Infant for Ventriculoperitoneal Shunt Meningitis.
PubMed 文献 · Pediatrics · 2016-12-14

本文报告一名5个月男婴因腹膜分流管相关脑膜炎,脑脊液培养出产超广谱β-内酰胺酶肺炎克雷伯菌,经美罗培南联合庆大霉素治疗4周后转为碳青霉烯耐药菌,移除感染分流管并置入外引流后,加用静脉替加环素(1.2 mg/kg 每日两次)及鞘内阿米卡星,替加环素治疗第6天脑脊液灭菌,总抗生素疗程为美罗培南60天、替加环素20天。作者强调替加环素缺乏儿童随机对照疗效与安全性数据,仅应作为无替代方案的危重患儿联合挽救治疗。

要点

  • 分流管感染中革兰阴性菌报告增多且死亡率更高,碳青霉烯耐药时治疗困难。
  • 替加环素未获批用于儿童,仅在无替代方案的危重患儿中作为联合挽救治疗。
  • 本例替加环素1.2 mg/kg每日两次联合美罗培南及鞘内阿米卡星,第6天脑脊液灭菌。

核心结论

  • 替加环素可作为无替代治疗方案的危重患儿腹膜分流管相关多重耐药革兰阴性菌脑膜炎的联合挽救治疗选择。

研究设计与样本

  • 单例病例报告:一名5个月男婴,腹膜分流管相关脑膜炎,脑脊液培养为产超广谱β-内酰胺酶肺炎克雷伯菌。

主要发现

  • 美罗培南联合庆大霉素治疗第4周末,脑脊液培养出碳青霉烯耐药肺炎克雷伯菌(美罗培南MIC>4 μg/mL,E-test法)。
  • 移除感染分流管并置入外引流后,加用静脉替加环素(1.2 mg/kg每剂,每日两次)及鞘内阿米卡星,替加环素治疗第6天脑脊液灭菌。
  • 抗生素总疗程为美罗培南60天、替加环素20天,鞘内阿米卡星仅可给予7天。

关键数值与推荐

  • 替加环素剂量为1.2 mg/kg每剂,每日两次,静脉给药。
  • 碳青霉烯耐药判定:美罗培南MIC>4 μg/mL(E-test法)。
  • 替加环素仅作为挽救治疗,需联合其他药物,用于无替代治疗方案的危重患儿。

临床怎么用

  • 对碳青霉烯耐药革兰阴性菌所致分流管脑膜炎,在移除感染分流管并外引流基础上,可考虑替加环素联合方案作为挽救治疗。
  • 替加环素用于儿童需权衡缺乏随机对照疗效与安全性数据,仅限无替代方案的危重病例。

局限性

  • 单例病例报告,无法提供替加环素在儿童中的疗效与安全性证据。
  • 缺乏随机对照研究数据,替加环素必须仅作为联合挽救治疗使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Shunt infections are seen in 3% to 20% of patients who have cerebrospinal fluid (CSF) shunts. Although the staphylococcal species are the most common cause of shunt-related infections, Gram-negative bacteria are increasingly reported with higher mortality rates. Tigecycline, a glycylcycline, is not approved for children. But in the era of nosocomial infections due to multidrug-resistant pathogens, it can be the life-saving option. We report an infant with ventriculoperitoneal shunt-related meningitis treated with a tigecycline combination regimen. A 5-month-old boy who had a ventriculoperitoneal shunt was admitted with meningitis. Extended spectrum β-lactamase-producing Klebsiella pneumoniae grew in the CSF. At the end of the fourth week of intravenous meropenem plus gentamicin therapy, carbapenem-resistant K pneumoniae grew in the CSF (mean inhibitory concentration value for meropenem >4 μg/mL, by E-test). The infected shunt was removed, and an external ventricular drainage catheter was inserted. With permission, intravenous tigecycline (1.2 mg/kg per dose twice a day) and intrathecal amikacin were added to the meropenem. Intrathecal amikacin could be given for only 7 days. On the sixth day of tigecycline treatment, the CSF was sterilized. Antibiotic therapy was given and consisted of a total of 60 days of meropenem and 20 days of tigecycline therapy. Because no available efficacy and safety data from randomized-controlled studies exist, tigecycline must be used only as salvage therapy, in combination with other drugs, for critically ill children who have no alternative treatment options.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Emiroglu M, Alkan G, Turk Dagi H, et al. Tigecycline Therapy in an Infant for Ventriculoperitoneal Shunt Meningitis. Pediatrics. 2016. PMID: 27974589. doi:10.1542/peds.2016-0963

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。